For patients with ductal carcinoma in situ (DCIS), active monitoring (AM) is noninferior to guideline-concordant care (GCC) ...

The first study comparing surgery to active monitoring as treatment for ductal carcinoma in situ (DCIS) finds women who carefully monitor the precancerous cells are no more likely to develop breast ...

One new study, published in the New England Journal of Medicine, examines whether removing lymph nodes is always necessary in ...

Two recent studies explore options for early-stage breast cancer patients to reduce surgery. One suggests active monitoring ...

Research presented at the San Antonio Breast Cancer Symposium suggests women with early-stage breast cancer could safely ...

The research, published in JAMA, suggests that active monitoring could be a viable alternative to surgery and radiation for low-risk patients with ductal carcinoma in situ (DCIS), known as stage zero ...

For patients with "good-risk" ductal carcinoma in situ (DCIS) who underwent breast- conserving surgery and did not receive ...

Some physicians who were not involved in the research cautioned that the study period was too short to draw firm conclusions, The Wall Street Journal reported. Researchers acknowledged longer-term ...

A new study from researchers at The University of Texas MD Anderson Cancer Center finds that ... molecular diagnostics along with ductal carcinoma in situ (DCIS) and biopsies, these findings ...

A new study finds that, in healthy women, some breast cells that otherwise ... using molecular diagnostics along with ductal carcinoma in situ (DCIS) and biopsies, these findings pose a challenge ...

Over the last decade, it has become widely accepted that there is indeed considerable overdiagnosis of both ductal carcinoma in situ and invasive breast cancer. As many as one in three breast ...